Yuhan Corp

Yuhan Corp maintains a conservative capital structure with a debt-to-equity ratio of 0.15 and a current ratio of 2.06, indicating strong short-term liquidity. The balance sheet shows total assets of 3.22 trillion KRW against total liabilities of 914 billion KRW, with cash and equivalents standing at 348 billion KRW. Long-term debt is limited to 343 billion KRW, resulting in a net cash position that supports financial flexibility. The risk assessment confirms low liquidity risk, aligning with the robust current ratio and ample cash reserves.

Profitability metrics show a return on equity (ROE) of 9.2% and a return on assets (ROA) of 6.59%. The company generated net income of 194 billion KRW on revenue of 2.19 trillion KRW, yielding a net margin of approximately 8.9%. Operating income was 184 billion KRW, while gross profit stood at 730 billion KRW, reflecting a gross margin of roughly 33.4%. Without cohort median data for direct comparison, these returns are evaluated against the company's historical performance and industry norms for pharmaceutical firms, which typically require significant R&D investment that may pressure near-term margins.

Revenue concentration and segment details are not explicitly provided in the available data, preventing a detailed analysis of geographic or product mix exposure. The company's total revenue of 2.19 trillion KRW serves as the baseline for valuation, with an EV/Revenue multiple of 2.3. The absence of segment data limits the ability to assess diversification risks or growth drivers within specific business lines.

Growth trajectory analysis is constrained by the absence of historical period data in the input. The latest normalized period shows revenue of 2.19 trillion KRW and net income of 194 billion KRW. Without prior year or quarterly trends, year-over-year growth rates cannot be calculated, leaving the momentum of the business unclear from the provided snapshot.

Risk factors are assessed as low for both liquidity and dilution. The company has no immediate filing-based flags for liquidity or dilution, and the share count remains stable with 73.6 million basic and diluted shares outstanding. The low dilution risk is further supported by the absence of recent equity issuance events in the observations.

Recent events include analyst estimates with a mean price target of 126,857 KRW and a median target of 135,000 KRW, suggesting significant upside potential from the current market price of 69,600 KRW. The mean recommendation is 2.00, with 6 strong buys and 9 buys, indicating positive sentiment among analysts. No specific filing, news, or transcript observations were provided to detail recent corporate actions or strategic shifts.

Analysts project 81.5% upside to a mean price target of 126,857 KRW, signaling strong market confidence.

Net income surged 174.6% year-over-year to 194 billion KRW in FY2026, demonstrating robust profitability growth.

Operating income expanded 492.5% year-over-year to 184 billion KRW, indicating significant operational leverage and efficiency gains.

Free cash flow turned positive at 68.5 billion KRW in FY2026, reversing previous deficits and improving liquidity.

Long-term debt increased to 304.6 billion KRW in FY2025, reflecting a rising leverage burden on the balance sheet.

Cash conversion ratio of 0.50 is below the cohort median of 1.20, suggesting weaker cash generation efficiency.

Capex intensity of -6.51% is below the cohort median of -3.74%, indicating higher capital expenditure relative to revenue.

Revenue growth of 5.7% year-over-year in FY2026 is modest, potentially limiting top-line expansion momentum.

Revenue KRW 526.78B, +7,2% YoY; Operating income −23,0% YoY.

• ▍Revenue KRW 526.78B, +7,2% YoY
• ▍Operating income −23,0% YoY
• ▍Net income +206,4% YoY
• ▍Free cash flow +592,7% YoY
• ▍Net margin 5.1%

Revenue KRW 546.07B, +10,1% YoY; Operating income +363,0% YoY.

• ▍Revenue KRW 546.07B, +10,1% YoY
• ▍Operating income +363,0% YoY
• ▍Net income +1 094,1% YoY
• ▍Free cash flow +228,2% YoY
• ▍Net margin 21.0%

Revenue KRW 570.01B, −4,8% YoY; Operating income −51,0% YoY.

• ▍Revenue KRW 570.01B, −4,8% YoY
• ▍Operating income −51,0% YoY
• ▍Net income −32,4% YoY
• ▍Free cash flow −12,2% YoY
• ▍Net margin 4.4%

Revenue KRW 578.99B, +9,6% YoY; Operating income +244,7% YoY.

• ▍Revenue KRW 578.99B, +9,6% YoY
• ▍Operating income +244,7% YoY
• ▍Net income +42,0% YoY
• ▍Free cash flow −115,1% YoY
• ▍Net margin 7.9%

Revenue KRW 491.56B; Operating income KRW 11.45B.

• ▍Revenue KRW 491.56B
• ▍Operating income KRW 11.45B
• ▍Net margin 1.8%

Revenue KRW 496.10B; Operating income -KRW 33.02B.

• ▍Revenue KRW 496.10B
• ▍Operating income -KRW 33.02B
• ▍Net margin -2.3%

Revenue KRW 598.78B; Operating income KRW 44.91B.

• ▍Revenue KRW 598.78B
• ▍Operating income KRW 44.91B
• ▍Net margin 6.3%

Revenue KRW 528.31B; Operating income KRW 18.54B.

• ▍Revenue KRW 528.31B
• ▍Operating income KRW 18.54B
• ▍Net margin 6.1%

Revenue KRW 2.19T, +5,8% YoY; Operating income +492,5% YoY.

• ▍Revenue KRW 2.19T, +5,8% YoY
• ▍Operating income +492,5% YoY
• ▍Net income +174,6% YoY
• ▍Free cash flow +238,8% YoY
• ▍Net margin 8.9%

Revenue KRW 2.07T, +11,2% YoY; Operating income −67,6% YoY.

• ▍Revenue KRW 2.07T, +11,2% YoY
• ▍Operating income −67,6% YoY
• ▍Net income −48,1% YoY
• ▍Free cash flow +10,6% YoY
• ▍Net margin 3.4%

Revenue KRW 1.86T, +4,7% YoY; Operating income +286,9% YoY.

• ▍Revenue KRW 1.86T, +4,7% YoY
• ▍Operating income +286,9% YoY
• ▍Net income +43,1% YoY
• ▍Free cash flow −587,2% YoY
• ▍Net margin 7.3%

Revenue KRW 1.78T, +5,2% YoY; Operating income −31,6% YoY.

• ▍Revenue KRW 1.78T, +5,2% YoY
• ▍Operating income −31,6% YoY
• ▍Net income −7,2% YoY
• ▍Free cash flow −73,5% YoY
• ▍Net margin 5.4%